Cell Harvesting System Market to Reach US$ 15.5 Bn by 2032, Says Persistence Market Research

The global cell harvesting system market has emerged as a critical segment within the biopharmaceutical and regenerative medicine industry. Cell harvesting refers to the isolation of target cells from growth media, an essential step in biologic manufacturing, cell-based therapies, and regenerative medicine. Traditionally, this process relied heavily on manual techniques such as centrifugation and depth filtration, which often posed challenges in consistency, throughput, and scalability. However, with increasing automation and technological innovations, cell harvesting systems have evolved to deliver improved reliability, accuracy, and efficiency. According to Persistence Market Research, the market is poised for robust expansion in the coming years, driven by the rising adoption of automated solutions.

Globally, the cell harvesting system market size is expected to reach US$ 6.9 billion in 2025, with forecasts projecting growth to US$ 15.5 billion by 2032, registering a CAGR of 12.2% during the 2025-2032 period. Key growth drivers include escalating demand for personalized medicine, stem cell therapies, and cell-based treatments, alongside increasing investments in research and development. Among segments, automated cell harvesters are leading the market due to superior efficiency and precision, while North America dominates geographically, attributed to its advanced biopharmaceutical infrastructure, robust research initiatives, and regulatory support.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/34752

Key Highlights from the Report

• Automated cell harvesters projected to capture 67.4% revenue share by 2025.
• Expansion of regenerative medicine and stem cell therapies drives market growth.
• Integration of AI and digital technologies enhances harvesting efficiency.
• Strategic partnerships and mergers accelerate technological innovation.
• Biopharmaceutical applications remain the dominant revenue-generating segment.
• North America leads globally due to high investments in cell-based research.

Market Segmentation

The cell harvesting system market can be segmented by product type and end-user applications, reflecting technological preferences and application-specific requirements. By product type, automated systems, including tangential flow filtration (TFF) platforms and continuous centrifuges, dominate over manual systems, offering high throughput, reproducibility, and scalability. Manual methods, while cost-effective for small-scale operations, are gradually being replaced due to labor-intensive procedures and high contamination risks. Persistence Market Research highlights the rising adoption of single-use technologies and robotic-assisted harvesters as key contributors to segment growth.

In terms of application, biopharmaceutical companies are the primary end-users, leveraging cell harvesting systems for monoclonal antibody production, cell-based therapies, and vaccine manufacturing. Academic and research institutions are also significant consumers, utilizing advanced cell harvesting platforms for stem cell research, gene therapy studies, and disease modeling. The increasing trend toward personalized medicine and regenerative therapies underscores the need for precise, scalable, and automated solutions across these sectors.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/cell-harvesting-system-market.asp

Regional Insights

North America holds a leading position in the cell harvesting system market, driven by advanced biopharmaceutical infrastructure and high R&D investments. The United States, in particular, benefits from a favorable regulatory framework, strategic collaborations between academia and industry, and a strong focus on personalized medicine initiatives. Government grants and funding for stem cell research further reinforce North America's dominant role.

Europe and Asia Pacific are emerging as key growth regions. Europe benefits from supportive regulatory policies, research funding, and rapid adoption of modern biomanufacturing technologies. Asia Pacific, with its expanding biotech hubs and increasing government investment in regenerative medicine, is witnessing rapid market growth. Countries like Japan, China, and India are increasingly adopting automated systems to meet rising demand for advanced therapies and biopharmaceutical products.

Market Drivers

Automation and innovation serve as primary drivers for the cell harvesting system market. Advanced automated platforms, including modular and robotic-assisted systems, significantly reduce manual intervention, improve yield consistency, and streamline workflows. For example, the Sefia cell therapy manufacturing platform by Cytiva in collaboration with Kite (Gilead) automates CAR-T cell therapy steps, minimizing contamination risks and accelerating production. Additionally, integration with AI and lab-on-a-chip technologies enables real-time monitoring and predictive process optimization, supporting scalability and operational efficiency.

Market Restraints

Despite strong growth prospects, the market faces challenges due to high costs and reliance on legacy systems. Automated systems such as TFF and continuous centrifuges require substantial capital investment, extensive qualification, and process optimization. Many facilities remain reliant on manual centrifugation and depth filtration, which reduces economies of scale and slows adoption. Furthermore, complex regulatory requirements and slow uptake across smaller facilities hinder the broader implementation of cutting-edge automated solutions globally.

Market Opportunities

Emerging technologies present significant opportunities within the cell harvesting system market. Innovations such as dissolvable microcarriers, 3D-printed microfluidic platforms, and automated single-cell harvesting systems enable scalable, sterile, and precise cell processing. These advancements facilitate the development of pluripotent stem cells, personalized therapies, and high-throughput biomanufacturing. Increased collaboration among industry players, startups, and academic institutions further expands R&D capabilities, enabling new applications in regenerative medicine and biopharmaceutical production.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/34752

Reasons to Buy the Report

• Comprehensive insights on global market size, trends, and forecasts from 2025 to 2032.
• Detailed analysis of product types, applications, and leading end-user segments.
• Strategic competitive intelligence with company profiles and recent market developments.
• Regional analysis highlighting emerging markets and growth opportunities.
• In-depth coverage of market drivers, restraints, and opportunities for strategic planning.

Frequently Asked Questions (FAQs)

• How Big is the Cell Harvesting System Market?
• Who are the Key Players in the Global Market for Cell Harvesting Systems?
• What is the Projected Growth Rate of the Cell Harvesting System Market?
• What is the Market Forecast for 2032?
• Which Region is Estimated to Dominate the Industry through the Forecast Period?

Company Insights

The global cell harvesting system market is characterized by the presence of established players and innovative startups, emphasizing technological advancements and strategic collaborations. Key market participants include:

• Esco Micro Pte. Ltd.
• Sartorius AG
• Cytiva (Danaher)
• Technical Proteins Nanobiotechnology
• Beckman Coulter, Inc
• Thermo Fisher Scientific Inc.
• Dr. Mueller AG
• Corning Incorporated
• PerkinElmer
• Revvity
• Smart MCs PTY LTD
• CARR Biosystems
• ScaleReady USA
• SINFONIA TECHNOLOGY CO., LTD.
• Cole-Parmer Instrument Company, LLC
• Human Med
• ADS Biotec Inc.
• Akadeum Life Sciences
• AVITA Medical

Recent Market Developments

• In June 2025, Sphere Fluidics launched Cyto?Mine Chroma, enhancing single-cell analysis with automated isolation and harvesting capabilities for biopharma workflows.
• In December 2024, Ori Biotech Ltd. partnered with Fresenius Kabi to integrate the IRO® platform with Cue® and Lovo® Cell Processing Systems, creating a streamlined closed cell therapy manufacturing workflow.

Conclusion

The cell harvesting system market is on a significant growth trajectory, driven by automation, technological innovations, and expanding applications in regenerative medicine and biopharmaceutical production. The rising demand for personalized therapies, stem cell-based treatments, and efficient biomanufacturing platforms positions automated systems at the forefront of market expansion. Regions like North America, Europe, and Asia Pacific are witnessing strong growth due to supportive regulatory frameworks, investments in R&D, and expanding biotech infrastructures.

Persistence Market Research emphasizes that strategic partnerships, continuous technological evolution, and the adoption of scalable automated platforms will be crucial in sustaining growth across the forecast period. Companies investing in innovation, process integration, and global expansion are well-positioned to capitalize on emerging opportunities, while overcoming challenges related to cost and legacy infrastructure. With ongoing advancements in AI, lab-on-a-chip, and microfluidic technologies, the global cell harvesting system market is poised for transformative growth, shaping the future of biopharmaceutical manufacturing and personalized medicine.

Read More Related Reports:

Esophageal Atresia Treatment Market https://www.persistencemarketresearch.com/market-research/esophageal-atresia-treatment-market.asp
Melanoma Skin Cancer Diagnostic Testing Market https://www.persistencemarketresearch.com/market-research/melanoma-skin-cancer-diagnostic-testing-market.asp
Facial Bone Contouring Market https://www.persistencemarketresearch.com/market-research/facial-bone-contouring-market.asp
Oral Solid Dosage Contract Manufacturing Market https://www.persistencemarketresearch.com/market-research/oral-solid-dosage-contract-manufacturing-market.asp
Metabolomics Biomarker Market https://www.persistencemarketresearch.com/market-research/metabolomics-biomarker-market.asp

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.